You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancer

 

Online download statistics by month:

Online download statistics by month: November 2021 to January 2026

AbstractFullPdf
Nov 2021751753246
Dec 2021396397127
Jan 202221422585
Feb 202214615365
Mar 202214815167
Apr 202214415274
May 202218218872
Jun 202216218089
Jul 202212613358
Aug 202219720265
Sep 202223825277
Oct 202221222189
Nov 202213113162
Dec 202210210437
Jan 202313313555
Feb 202314414420
Mar 2023929635
Apr 2023555625
May 2023767634
Jun 20239910428
Jul 2023959641
Aug 20239810143
Sep 202313613826
Oct 202310611032
Nov 202324224229
Dec 202315916187
Jan 20247677107
Feb 2024666624
Mar 2024788142
Apr 202410210355
May 2024656821
Jun 2024979638
Jul 2024858431
Aug 2024414319
Sep 2024495031
Oct 20246974943
Nov 2024616232
Dec 2024757618
Jan 2025787838
Feb 202519119136
Mar 2025747435
Apr 2025858645
May 2025454628
Jun 2025323617
Jul 2025110
Jan 2026110
Total595560943228